Related Experiment Video
Updated: Jan 24, 2026

Classical Short-Delay Eyeblink Conditioning in One-Year-Old Children
Published on: September 1, 2018
Evaluation of Atrial Electromechanical Delay in Children with Obesity
Fatih Temiz1, Hatice Güneş2, Hakan Güneş3
1Sutcu Imam University, Department of Pediatric Endocrinology, 46100 Kahramanmaras, Turkey. ftemiz2003@yahoo.com.
Insights
Obese children show prolonged electromechanical delay (EMD), a predictor of atrial fibrillation. Increased body mass index (BMI) in these children is linked to longer EMD, suggesting a heightened cardiovascular risk.
Area of Science:
- Cardiology
- Pediatrics
- Biomedical Engineering
Background:
- Childhood obesity is a growing global health concern.
- Obesity is linked to increased morbidity, mortality, and cardiovascular diseases.
- Electromechanical delay (EMD) is a known predictor of atrial fibrillation (AF).
Purpose of the Study:
- To investigate if electromechanical delay (EMD) is prolonged in obese children.
- To determine the relationship between body mass index (BMI) and EMD in pediatric obesity.
- To assess EMD as a potential risk factor for cardiovascular issues in obese youth.
Main Methods:
- The study included 59 obese children (8-18 years) and 38 healthy controls.
- Transthoracic echocardiography and tissue Doppler imaging were used.
- Measurements included left ventricular function and inter-/intra-atrial EMD.
Main Results:
- Obese children exhibited significantly longer P-wave to diastolic wave intervals (PA lateral, PA septum) and inter-/intra-atrial EMD compared to controls (p < 0.001).
- Inter-atrial EMD and intra-atrial EMD positively correlated with BMI (r = 0.484, p < 0.001 and r = 0.376, p = 0.001, respectively).
- BMI was a significant independent predictor of inter-atrial EMD (β = 0.473, p < 0.001).
Conclusions:
- Electromechanical delay is significantly increased in obese children compared to healthy controls.
- Intra- and inter-atrial EMD are correlated with body mass index in obese children.
- BMI is an independent predictor of inter-atrial EMD in this pediatric population.
Abstract:
Background and Objective: Childhood obesity is one of the worldwide health problems with an increasing prevalence and accompanied by severe morbidity and mortality. It is a serious predisposing risk factor especially for the development of cardiovascular diseases and arrhythmias. Electromechanical delay (EMD) is known to be a predictor for the development of atrial fibrillation (AF). Our study aims to investigate whether EMD, which is a predictor of AF, prolongs in obese children or not.
Material And Methods:
The study included 59 obese patients aged between 8-18 years and 38 healthy patients as the control group with a similar age and gender. All the individuals underwent transthoracic echo and tissue Doppler echocardiography. Systolic and diastolic left ventricular (LV) functions, inter- and intra-atrial electromechanical delay were measured by tissue Doppler imaging (TDI) and conventional echocardiography.
Results:
Obese patients had significantly lengthened P-wave on surface ECG to the beginning of the late diastolic wave (PA) lateral, PA septum, intra- and inter-atrial electromechanical delays when compared with the control group (p < 0.001, p = 0.001, p < 0.001 and p < 0.001, respectively) Inter-atrial EMD and intra-atrial EMD correlated positively with body mass index (BMI) values (r = 0.484, p < 0.001 and r = 0.376, p = 0.001; respectively) BMI was significantly related with inter-atrial EMD (β = 0.473, p < 0.001) However, there was no relationship between inter-atrial EMD and serum glucose and platelet count.
Conclusion:
In our study, we declared that electromechanical delay was increased in obese children when compared to the control group and intra- and inter-atrial electromechanical delay was in correlation with body mass index. Furthermore, we discovered that BMI is an independent predictor of the inter-atrial EMD in obese children.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Drug Dosing: Infants and Children
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

